找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Basic and Clinical Applications of Flow Cytometry; Proceeding of the 24 Frederick A. Valeriote,Alexander Nakeff,Manuel Val Conference proce

[復(fù)制鏈接]
樓主: 多愁善感
21#
發(fā)表于 2025-3-25 04:54:42 | 只看該作者
DNA Flow Cytometry Application to Clinical Trials in Breast Cancer, one of the best opportunities to assess new treatment strategies as well as evaluate new prognostic markers. Several prognostic factors are currently being evaluated in a number of clinical trials throughout the United States, the most well established of these markers is DNA flow cytometry.
22#
發(fā)表于 2025-3-25 08:59:52 | 只看該作者
23#
發(fā)表于 2025-3-25 11:54:01 | 只看該作者
The Clinical Potential of DNA Content Parameters in Human Pediatric and Adult Solid Tumors, technologies have evolved which have allowed the careful correlation of pathological features of tumors and the clinical outcome of the patients that harbor them. Until very recently, individual patient treatment decisions and the design of clinical trials were based primarily on these two types of parameters; clinical stage and histopathology.
24#
發(fā)表于 2025-3-25 16:08:37 | 只看該作者
The Molecular Basis for the Control of Mammalian Cell Growth, have been many spectacular advances in our understanding of the molecular processes that regulate cell proliferation. This review will outline our current understanding of the major features of cell growth regulation in mammalian cells.
25#
發(fā)表于 2025-3-25 22:06:33 | 只看該作者
26#
發(fā)表于 2025-3-26 01:44:12 | 只看該作者
EPR Investigation of [NiFe] Hydrogenases have been many spectacular advances in our understanding of the molecular processes that regulate cell proliferation. This review will outline our current understanding of the major features of cell growth regulation in mammalian cells.
27#
發(fā)表于 2025-3-26 07:04:28 | 只看該作者
28#
發(fā)表于 2025-3-26 09:52:54 | 只看該作者
29#
發(fā)表于 2025-3-26 14:05:03 | 只看該作者
30#
發(fā)表于 2025-3-26 20:31:42 | 只看該作者
Maurice van Gastel,Wolfgang Lubitz functions and operates by forming temporary gates in double stranded DNA (Fig. 1) through which an intact helix can pass. Several classes of antitumor drugs are now recognized as topoisomerase poisons because of their ability to trap the enzyme gates on DNA in the form of stabilized cleavable complexes (Fig. 1).
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 16:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
银川市| 西城区| 红河县| 信丰县| 博野县| 高唐县| 龙泉市| 万源市| 广元市| 柯坪县| 寿阳县| 拜泉县| 鄂伦春自治旗| 眉山市| 巴东县| 富阳市| 阳新县| 苏尼特右旗| 康定县| 南通市| 神木县| 玉山县| 平遥县| 治县。| 开远市| 涞源县| 庐江县| 大竹县| 乌恰县| 巴里| 大足县| 沁水县| 宁国市| 万盛区| 府谷县| 革吉县| 南丹县| 富顺县| 浏阳市| 东海县| 抚顺县|